Our results from 113 people with known T2DM not on insulin treatment at the time of hospitalisation for SARS-CoV-2 infection between April and March 2020 demonstrate that 35% of people with known diabetes required insulin as a new treatment during their hospitalisation. This evidence concerns the gene INS and type 2 diabetes mellitus.